Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin in muscle tension dysphonia
IRCT20210320050749N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in muscle tension dysphonia (MTD) and Functional dysphonia (FD) comparing Gabapentin with Placebo (2 arms). Primary endpoints: Jitter, Shimmer and 3 more. Started Apr 2021; status: completed.
02
Drugs
gabapentin
03
Conditions
muscle tension dysphonia (MTD)Functional dysphonia (FD)
Beyond the preview
Go deeper on IRCT20210320050749N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210320050749N1.